Cereno Scientific AB (publ) (STO:CRNO.B)
Sweden
· Delayed Price · Currency is SEK 6.00
-0.07 (-1.15%)
At close: Mar 6, 2026
Cereno Scientific AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 44.27 | 80.9 | 49.28 | 57.54 | 44.81 | Upgrade
|
| Revenue | 44.27 | 80.9 | 49.28 | 57.54 | 44.81 | Upgrade
|
| Revenue Growth (YoY) | -45.28% | 64.18% | -14.36% | 28.42% | 444.85% | Upgrade
|
| Gross Profit | 44.27 | 80.9 | 49.28 | 57.54 | 44.81 | Upgrade
|
| Selling, General & Admin | 117.74 | 154.5 | 89.9 | 84.12 | 59.57 | Upgrade
|
| Other Operating Expenses | 0.35 | - | 3.6 | - | - | Upgrade
|
| Operating Expenses | 118.88 | 154.78 | 93.51 | 84.13 | 59.59 | Upgrade
|
| Operating Income | -74.6 | -73.88 | -44.24 | -26.6 | -14.78 | Upgrade
|
| Interest Expense | -44.55 | -26.09 | -5.3 | -0.46 | -1.25 | Upgrade
|
| Interest & Investment Income | 1.4 | 2.4 | 1.84 | 0.31 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -1.96 | -0.41 | -0.9 | -0.23 | Upgrade
|
| Pretax Income | -117.75 | -99.53 | -48.11 | -27.65 | -16.25 | Upgrade
|
| Income Tax Expense | - | - | - | 0.01 | 0 | Upgrade
|
| Net Income | -117.75 | -99.53 | -48.11 | -27.65 | -16.25 | Upgrade
|
| Net Income to Common | -117.75 | -99.53 | -48.11 | -27.65 | -16.25 | Upgrade
|
| Shares Outstanding (Basic) | 296 | 282 | 234 | 138 | 105 | Upgrade
|
| Shares Outstanding (Diluted) | 296 | 282 | 234 | 138 | 105 | Upgrade
|
| Shares Change (YoY) | 5.11% | 20.50% | 70.00% | 30.64% | 44.58% | Upgrade
|
| EPS (Basic) | -0.40 | -0.35 | -0.21 | -0.20 | -0.15 | Upgrade
|
| EPS (Diluted) | -0.40 | -0.35 | -0.21 | -0.20 | -0.15 | Upgrade
|
| Free Cash Flow | -111.93 | -107.29 | -36.92 | -18.62 | -13.14 | Upgrade
|
| Free Cash Flow Per Share | -0.38 | -0.38 | -0.16 | -0.14 | -0.13 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -168.50% | -91.32% | -89.78% | -46.22% | -32.99% | Upgrade
|
| Profit Margin | -265.97% | -123.02% | -97.63% | -48.06% | -36.28% | Upgrade
|
| Free Cash Flow Margin | -252.82% | -132.62% | -74.91% | -32.35% | -29.32% | Upgrade
|
| EBITDA | -73.81 | -73.59 | -44.22 | -26.58 | -14.77 | Upgrade
|
| EBITDA Margin | -166.72% | -90.96% | -89.75% | -46.20% | -32.96% | Upgrade
|
| D&A For EBITDA | 0.79 | 0.29 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | -74.6 | -73.88 | -44.24 | -26.6 | -14.78 | Upgrade
|
| EBIT Margin | -168.50% | -91.32% | -89.78% | -46.22% | -32.99% | Upgrade
|
| Revenue as Reported | 44.27 | 80.9 | 49.28 | 57.54 | 44.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.